SYNTHETIC LONG PEPTIDES (SLP) FOR THERAPEUTIC VACCINATION AGAINST HEPATITIS B VIRUS INFECTION

The present invention relates to the fields of medicine and immunology. In particular, it relates to novel peptides that may be used in the treatment and/or prevention of a Hepatitis B viral infection and/or an Hepatitis B related disease or condition.

Saved in:
Bibliographic Details
Main Authors KREBBER Wilhelmus Johannes Theodorus Alexander, KWAPPENBERG Kitty Michelle Corinne, KESSLER Johan Herman, MELIEF Cornelis Joseph Maria
Format Patent
LanguageEnglish
Published 31.08.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to the fields of medicine and immunology. In particular, it relates to novel peptides that may be used in the treatment and/or prevention of a Hepatitis B viral infection and/or an Hepatitis B related disease or condition.
Bibliography:Application Number: US201515315526